Experts are predicting a novel coronavirus vaccine could be available by 2021, but the timeline for the creation of a new tuberculosis vaccine remains uncertain.

Landmark phase III trial shows that the shorter regimen containing rifapentine and moxifloxacin can safely and effectively cure TB in four months.

UN Secretary-General outlines priority recommendations to accelerate the TB response and reach targets.

LIFT-TB to increase treatment completion rates for drug-resistant TB, focusing on seven high-burden Southeast and Central Asian countries that shoulder about 1 in 5 TB case.

Public Health Action is the free access, online journal of The International Union Against Tuberculosis and Lung Disease. The journal focuses on TB, lung health, non-communicable diseases and related public health issues.

A new online tool which could help eliminate tuberculosis in countries with low transmission rates such as the UK, by identifying who is at highest risk of developing TB, has been developed by UCL researchers.

The new version of the World Health Organization (WHO) 2020 Global TB Report app is now available for free download in English, French and Russian.

The World Health Organization (WHO) Global TB Program is collecting case studies to document innovative approaches and lessons learnt to improve provision of TB services in times of COVID-19. As a first step, WHO invites staff from national TB programs and technical partners engaged in this field to send a short one-page abstract of relevant activities via this form.

Relapses occurred in only 4 of 14 patients treated with the combination of Metronidazole with Vancomycin.

If the world had forgotten the importance of vaccines, COVID-19 has served as a stark reminder. Less than a year after the emergence of SARS-CoV-2 (the virus that causes COVID-19), over a hundred vaccine candidates are under development and several large clinical trials are already under way, including some in South Africa. It is plausible that a safe and effective COVID-19 vaccine will be available within the next year or two, although only time and properly conducted trials will tell.